ClinicalTrials.gg
Not yet recruitingNCT07016100Updated Jun 15, 2025

Contingency Management to Reinforce Attendance to Cognitive Behavioral Treatment for Gambling Disorder

An interventional study of Contingency management and Cognitive behavioral therapy/ treatment as usual in Gambling Disorder and Gambling Problem, sponsored by East Tennessee State University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by East Tennessee State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to conduct a trial to investigate the effectiveness of adding contingency management treatment (CM) to standard care cognitive behavioral therapy (CBT) for the treatment of gambling disorder to increase attendance to treatment. CM will be used to incentivize therapy session attendance with a therapist and engagement in recovery-related engagement with a peer recovery specialist. The proposed research will evaluate whether CM can enhance the overall effectiveness of CBT, the most widely tested treatment for individuals with gambling disorder.

Read the detailed description

Cognitive behavioral therapy (CBT) has been established as the most efficacious treatment for gambling disorder. Unfortunately, 39% of those who seek treatment dropout before completing the prescribed treatment dose, a rate that is markedly higher than found with substance use treatment (30%) and mental health treatment (20%). Increasing attendance means more time to learn the skills needed to create and sustain change and, therefore, enhance treatment outcomes. To date, there has been a dearth of research on how to keep people in CBT for gambling disorder. A logical and promising option is using contingency management (CM), where tangible incentives (i.e., vouchers) are provided upon completion of a target behavior, such as treatment attendance. CM has robust support for increasing attendance to substance use treatment (68% of participants receiving CM increase their attendance). Surprisingly, CM has not been tested to motivate attendance in gambling treatment. The current project proposes to conduct a randomized controlled trial to establish the preliminary effectiveness of CM for the treatment of gambling disorder. CM will be used to incentivize attendance to CBT therapy sessions and engagement in peer recovery specialist (PRS)-facilitated recovery support activities. PRS are individuals with lived experience with recovery who use their personal experience and training to create opportunities for tailored support as a client seeking treatment navigates recovery. The selected CM protocol will provide direct gift card payments each time the participant attends a scheduled therapy or recovery activity session. Payments will start at $30 for a therapy session and $10 for a PRS-led activity session and escalate over 8 weeks of treatment. Participants will be recruited from those seeking treatment at our well-established gambling treatment center. All participants will receive a standard course of CBT treatment that includes weekly therapy sessions and PRS-support activities. Participants will be randomized to receive either CBT treatment as usual or CM+CBT, where participants will attend treatment as usual, and each session attended will be monetarily reinforced. The investigators will explore between treatment group changes in gambling behavior, treatment engagement, and other clinical covariates in these individuals at post-treatment and at a 3-month follow-up. Treatment gains will not be limited to strictly abstinence-focused outcomes and will allow for the coding of quantitative and qualitative decreases in gambling behavior and harm, and a calculation of the percentage of individuals who meet their self-selected treatment goal (which can range from abstinence to harm reduction). Results will instrumentally further our present understanding of how to enhance motivation for treatment attendance and clarify the mechanisms of CBT for gambling disorder.

02

Conditions studied

  • Gambling Disorder
  • Gambling Problem

Browse trials for

Keywords

  • contingency management
03

In context

Gambling

158 studies on the registry are indexed under Gambling; 42 are open to participants now.

This study's planned enrollment of 80 is above the median of 66 across 128 interventional studies indexed under Gambling.

Browse Gambling studies →

Lead sponsor

East Tennessee State University is the lead sponsor of 21 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults age 18 or older
  2. Seeking treatment for gambling-related concerns at The Gambling Clinic
  3. Available to meet weekly for eight treatment sessions without a known structural barrier to continuation that could interfere with study conclusions (e.g., planned relocation out of state).
  4. Proficient in English (assumed by request of gambling treatment in English).
  5. Must be physically present in the US.

Exclusion criteria

Exclusion Criteria:

  1. Minors under the age of 18.
  2. Recent history of psychotic symptoms or suicidal intent
  3. Not proficient in English.
  4. Seeking gambling treatment for someone other than themselves (e.g., a loved one).
  5. Will not be available for a full eight weeks of study participation.
  6. Not physically present in the US.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Contingency Management

    Contingency management is designed to reinforce treatment attendance. Participants will earn gift card vouchers for attendance to therapy sessions and recovery-related engagements with peer support specialists. This treatment is in addition to the standard care/ treatment as usual (cognitive behavioral therapy).

    Behavioral: Contingency management

  • Active comparator
    Cognitive Behavioral Treatment/ Treatment as Usual

    This five phase cognitive behavioral therapy addresses participants' behaviors, thoughts, and emotions to help them change their gambling.

    Behavioral: Cognitive behavioral therapy/ treatment as usual

Interventions

  • BehavioralContingency management

    See arm description

  • BehavioralCognitive behavioral therapy/ treatment as usual

    See arm description

06

What researchers measure

Primary outcomes

  1. Proportion of sessions attended out of total

    Time frame: From treatment start to the end of treatment at 8 weeks

Secondary outcomes

  1. Frequency of days gambled

    Number of days gambled per month

    Time frame: From 30 days prior to treatment start to the end of the 3-month follow-up window

  2. Net monetary expenditures in US $ on gambling

    Money spent gambling per month

    Time frame: From 30 days prior to treatment start to the end of the 3-month follow-up window

  3. Number of gambling symptoms

    Quantity of gambling disorder symptoms reported in the past month

    Time frame: From 30 days prior to treatment start to the end of the 3-month follow-up window

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07016100
Lead sponsor
East Tennessee State University
Responsible party
Sponsor
First posted
Jun 11, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Jun 15, 2025

Study contacts

Meredith K Ginley, Ph.D.
Contact
ginleym@etsu.edu
14234394113

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion